Pregnancy and Postpartum CGM in GDM
Gestational diabetes (GDM) is one of the most common complications of pregnancy, and up
to one third of women with GDM will have abnormal blood sugars after their pregnancy. To
screen for abnormal blood sugars, standard of care is a 4-12 week postpartum oral glucose
...
Age: 18 years - 66+
Gender: Female
CGM for the Early Detection and Management of Hyperglycemia in Pregnancy
The goal of this clinical trial is to use continuous glucose monitoring (CGM) to quickly
detect and manage high blood sugar in pregnant women, early in pregnancy. The main
questions it aims to answer are:
(1) any problems for the baby, such as being too large for t...
Age: 18 years - 66+
Gender: Female
EXpanding Prenatal Cell Free DNA Screening Across MoNogenic Disorders (EXPAND)
The purpose of this research is to develop and validate a single gene Non-Invasive
Prenatal Test. The development of this investigational single-gene noninvasive prenatal
testing (sgNIPT) for conditions such as cystic fibrosis (CF), spinal muscular atrophy
(SMA), Sic...
Age: 18 years - 66+
Gender: All
EXpanding Prenatal Cell Free DNA Screening Across moNogenic Disorders (EXPAND)
The purpose of this research is to develop and validate a single gene Non-Invasive
Prenatal Test. The development of this investigational single-gene noninvasive prenatal
testing (sgNIPT) for conditions such as cystic fibrosis (CF), spinal muscular atrophy
(SMA), Sic...
Age: 18 years - 66+
Gender: All
A Phase 2 Study of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
The goal of this Phase 2 clinical trial is to investigate the efficacy and safety of
NEU-411 in men and women aged 40-80 years with early Parkinson's Disease (PD) who have
predicted elevations in the activity of the "leucine-rich repeat kinase 2" ("LRRK2" for
short) ...
Age: 40 - 80 years
Gender: All
A Phase 2 Study of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
The goal of this Phase 2 clinical trial is to investigate the efficacy and safety of
NEU-411 in men and women aged 40-80 years with early Parkinson's Disease (PD) who have
predicted elevations in the activity of the "leucine-rich repeat kinase 2" ("LRRK2" for
short) ...
Age: 40 - 80 years
Gender: All
Inhaled Insulin vs Rapid-acting Injections for Post-meal Glucose Control in Women With Gestational Diabetes
Pregnant women aged 18-40 with gestational diabetes (GDM) will take part in this study.
We want to see how two different insulin treatments affect their blood sugar after they
eat. These women usually use a rapid-acting insulin analog (RAA) that's injected to
control...
Age: 18 - 40 years
Gender: Female
Inhaled Insulin vs Rapid-acting Injections for Post-meal Glucose Control in Women With Gestational Diabetes
Pregnant women aged 18-40 with gestational diabetes (GDM) will take part in this study.
We want to see how two different insulin treatments affect their blood sugar after they
eat. These women usually use a rapid-acting insulin analog (RAA) that's injected to
control...
Age: 18 - 40 years
Gender: Female
The Women With Inflammatory Bowel Disease and Motherhood (WIsDoM) Study - A Study Focused on Female Fertility and IBD
View WIsDoM Study Promo Video
What is the purpose of the study?
Many patients with Crohn’s disease or ulcerative colitis are women who are diagnosed with the disease during peak childbearing years. Both patients and providers frequently ask whether IBD, IBD...
Age: 18 - 45 years
Gender: Female
Enhancing Access to Supportive Services for Women of Color with Metastatic Breast Cancer
Black and Latina women experience disparities in supportive and palliative care access
and outcomes. The goal of the proposed pilot study is to evaluate the feasibility and
acceptability of a community navigator delivered supportive care intervention for
historically...
Age: 18 years - 66+
Gender: Female
Enhancing Access to Supportive Services for Women of Color With Metastatic Breast Cancer
Black and Latina women experience disparities in supportive and palliative care access
and outcomes. The goal of the proposed pilot study is to evaluate the feasibility and
acceptability of a community navigator delivered supportive care intervention for
historically...
Age: 18 years - 66+
Gender: Female
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women
This is a research study in women to compare the outcomes of two procedures that restore
blood flow to the arteries of the heart. In one procedure the blockages are ballooned and
then stented with a small wire mesh tube through a small incision in the wrist or the
gr...
Age: 18 years - 66+
Gender: All
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women
This is a research study in women to compare the outcomes of two procedures that restore
blood flow to the arteries of the heart. In one procedure the blockages are ballooned and
then stented with a small wire mesh tube through a small incision in the wrist or the
gr...
Age: 18 years - 66+
Gender: All
Pregnant Women With and Without Crohns Disease to Explore the Role of Plastics and Toxins in Intestinal Inflammation
The PLANET Study aims to determine the impact of microplastics on intestinal inflammation
and gut microbiome in order to understand the role of this pollutant on the risk of
developing inflammatory bowel disease (IBD) as well as other diseases. With this
information,...
Age: 18 years - 66+
Gender: All
Pregnant Women With and Without Crohns Disease to Explore the Role of Plastics and Toxins in Intestinal Inflammation
The PLANET Study aims to determine the impact of microplastics on intestinal inflammation
and gut microbiome in order to understand the role of this pollutant on the risk of
developing inflammatory bowel disease (IBD) as well as other diseases. With this
information,...
Age: 18 years - 66+
Gender: All
A Phase 3, SingleArm, OpenLabel Study to Evaluate the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women with Uterine Fibroids or Endometriosis who are 18 to 50 Years of Age and at Risk for Pregnancy
The purpose of this study is to evaluate if relugolix, given with low-dose estradiol (estrogen) and norethindrone acetate (progesterone) (referred to as relugolix combination therapy) is safe and works in the prevention of pregnancy in women with uterine fibroids or end...
Age: 18 - 50 years
Gender: Female
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
The goal of this clinical trial is to assess the efficacy, safety and tolerability of the
combination of lasofoxifene and abemaciclib compared to fulvestrant and abemaciclib for
the treatment of pre- and postmenopausal women and men who have previously received
riboc...
Age: 18 years - 66+
Gender: All
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
The goal of this clinical trial is to assess the efficacy, safety and tolerability of the
combination of lasofoxifene and abemaciclib compared to fulvestrant and abemaciclib for
the treatment of pre- and postmenopausal women and men who have previously received
riboc...
Age: 18 years - 66+
Gender: All
Neurofeedback During Eating for Bulimia Nervosa
The purpose of this study is to examine the effects of noninvasive prefrontal cortex
(PFC) neurofeedback during eating in women with bulimia nervosa (BN) using a wearable
brain imaging device, functional near-infrared spectroscopy (fNIRS). The investigators
will exam...
Age: 18 - 45 years
Gender: Female
Neurofeedback During Eating for Bulimia Nervosa
The purpose of this study is to examine the effects of noninvasive prefrontal cortex
(PFC) neurofeedback during eating in women with bulimia nervosa (BN) using a wearable
brain imaging device, functional near-infrared spectroscopy (fNIRS). The investigators
will exam...
Age: 18 - 45 years
Gender: Female